Introduction
As both glaucoma and cataract are increasingly frequent with increasing age, glaucoma patients undergoing cataract surgery are common. These patients require a carefully planned approach to achieve not only a successful cataract extraction outcome but, more importantly, long-term control of their glaucoma.
Clinical History
Is cataract surgery necessary? Determine the degree of visual disability from the cataract versus that from the glaucoma; for the patient, it is the summed visual disability that affects him or her. To have realistic expectations of the potential visual benefits from surgery, patients need to understand the difference. Unless visual loss from glaucoma in the two eyes overlaps, the irreversible glaucoma damage may not be obvious to the patient. Cataract-induced visual loss presents as progressive reduction in visual acuity and in loss of fine detail and contrast (especially in low light), and glare; if allowed to progress, this may threaten a patient's ability to drive and his or her ambulatory vision. In patients with both glaucomatous and cataractous loss, this distinction may not be clear: Glaucoma can manifest as paracentral scotomas, while cortical cataract can present as peripheral loss.
Preoperative Assessment
Glaucoma patients require the same careful preoperative examination as all cataract patients. Secondary G.A. Lee ( ) Department of Ophthalmology, Royal Brisbane Hospital, Brisbane, QLD 4029, Australia e-mail: eye@cityeye.com.au glaucomas present specific challenges during cataract surgery; preoperative surgical planning minimizes risks of complications.
Cornea
In well-controlled glaucoma, the cornea in most patients is normal for their age. Epithelial and stromal edema (e.g., with high intraocular pressure [IOP] , bullous keratopathy, and the iridocorneal endothelial [ICE] syndrome) interferes with visualization of intraocular structures (Figs. 1.1 and 1.2). Keratic precipitates may indicate previous uveitis ( Fig. 1.3 ). Moderate endothelial loss of around 7% has been observed following trabeculectomy compared with a loss of 2.6% following deep sclerectomy. 1 More endothelial loss occurs with two-site phacotrabeculectomy compared with onesite. 2 This may influence choice of procedure in already 
Gonioscopy
Vital in all patients, gonioscopic assessment of the angle is especially important in those with glaucoma. If less than 2.4 mm, anterior chamber depth is a significant risk factor for angle closure. 3 Occludable and partially closed angles often reopen following cataract removal ( Fig. 1.4a, b) ; however, there may be persistent peripheral anterior synechial closure ( Fig. 1.5 ). Intermittent iridotrabecular contact might explain 4 Trabecular meshwork pigment with radial transillumination defects indicates pigment dispersion ( Fig. 1.6a, b) . Pseudoexfoliative (PXF) material on the anterior lens capsule, iris, and meshwork indicates an increased risk of zonular and capsular weakness, and of lens dislocation ( Fig. 1.7 ; see also Chapter 15).
Optic Nerve
The neuroretinal rim is the key to diagnose glaucoma and to stage damage. Visual field loss should correspond to optic a b 
Silicone Oil
Silicone oil retinal tamponade following complicated vitreoretinal surgery may precipitate posterior subcapsular lens opacities and/or secondary glaucoma. Biometry in the presence of silicone oil is altered; Murray et al. 5 reported a mean ratio of true axial length to measured axial length of 0.71 ( Fig. 1.10 ). Calculated intraocular lens (IOL) power depends on whether the oil is to be retained or removed at the time of cataract surgery. Preserving the integrity of the posterior capsule is important to keep oil from entering the anterior segment; this reduces the probability of silicone oilinduced IOP increases and potential silicone oil keratopathy ( Fig. 1.11 ).
Investigations

Field Analysis
Mean deviation (MD) levels in standard automated perimetry indicate severity of visual loss from both glaucoma and cataract. Pattern standard deviation (PSD) or its equivalent reduces the effect of overall field depression from a uniform cataract ( Fig. 1.12a, b) . Visual field changes after cataract extraction in patients with advanced field loss 6 showed mean values for MD and PSD of -13.2 and 6.4 dB before and -11.9 and 6.8 dB after cataract surgery (P ≤ 0.001 for all comparisons). Mean (± SD) number of abnormal points on pattern deviation plot was 26.7 ± 9.4 and 27.5 ± 9.0 before and after cataract surgery, respectively (P = 0.02). Scotoma depth index did not change after cataract extraction (-19.3 versus -19.2 dB, P = 0.90). Cataract extraction generally improved the visual field; this was most marked in eyes with less advanced glaucomatous damage. Enlargement of scotomas was statistically significant, but was not clinically a b meaningful. No improvement of sensitivity was observed in the deepest part of the scotomas. In a subset of the Collaborative Initial Glaucoma Treatment Trial, visual field testing before and after cataract extraction showed an improved MD but a worse PSD. 7 Other studies have found improvement of the MD with no change in mean PSD on SITA perimetry. 8 Cai et al. showed the amplitude of the AccuMap (objective multifocal visual evoked potential perimetry) was increased after cataract surgery (382.6 nV ± 146.7 nV versus 308.0 nV ± 96.6 nV; P < 0.01). The AccuMap severity index (ASI) was decreased following lens removal (48.6 ± 42.4 versus 90.0 ± 54.8, P < 0.001; P < 0.001). 9 Focal lens opacities or cortical changes may simulate glaucomatous patterns of field loss, making it more difficult 
Ultrasonic Biometry
A-scan biometry measures anterior chamber depth and axial lengths. In angle closure, by removing a cataractous lens with a thickness of more than 4.5 mm and replacing it with a 1-mm-thick intraocular lens (IOL), cataract surgery deepens the anterior chamber and opens the angle ( Fig.  1.13a, b ). In eyes with shallow anterior chambers, the IOL position is usually more posterior than was the crystalline lens; an increase of 0.5 diopters to the calculated IOL power will be closer to emmetropia. A shallow anterior chamber presents an intraoperative challenge by increasing the risk of trauma to the corneal endothelium and iris. Myopically shifted prediction of refractive error is significantly more frequent following posterior chamber intraocular lens implantation with phacotrabeculectomy compared with phacoemulsification, even when surgery was uncomplicated and performed by the same surgeon. 11 Another study comparing refractive outcome from cataract surgery after successful trabeculectomy to cataract surgery only found no significant difference from the predicted refraction. 12 Combined cataract surgery and trabeculectomy with mitomycin C tends to shorten the axial length and induces a corneal astigmatism and increased mean keratometry. 13 Despite this alteration of the axial length and corneal curvature, the refractive outcome after a combined operation did not differ significantly from the predicted refraction. At present there is insufficient evidence to make firm recommendations as to the use of multifocal lenses in patients with glaucoma. 14 
Specular Microscopy/Pachymetry
Look for corneal endothelial compromise; expect it in the ICE syndrome or after penetrating keratoplasty. If the cell count is less than 500 viable cells/square millimeter and/or a b the central corneal thickness is greater than 640 µm, there is a significant risk of corneal decompensation post cataract surgery. 15 Combined corneal grafting and cataract removal is an option.
Imaging of the Nerve Fiber Layer
The thickness of the nerve fiber layer is a measure of optic nerve structural integrity. While it complements the clinical assessment of the neuroretinal rim, it may be useful in anomalous discs and when cup:disc ratio is not assessable ( Fig. 1.14a , b). If imaging demonstrates good preservation of the nerve fiber layer, then visual improvement following cataract surgery is more likely. Dense media opacities interfere with scan quality and thus measurement reliability. Savini et al. reported that cataract density influenced retinal nerve fiber layer (RNFL) thickness, as measured by optical coherence tomography (OCT) (Carl Zeiss Meditec, Dublin, CA). Postoperative measurements were higher than preoperative measurements in all quadrants (temporal P = 0.011; superior P = 0.0098; nasal P< 0.0001; inferior P = 0.0081) and in 360 • averages (P < 0.0001).
More advanced lens opacities correlated with a higher apparent decrease in RNFL thickness (r = 0.4071, P = 0.0434). While pupil size only marginally affected RNFL measurements performed by Stratus OCT, the presence and degree of cataract seemed to be significant. Consider this when using OCT to help diagnose glaucoma and other neuro-ophthalmologic disorders affecting the RNFL in the presence of a cataract. 16 
Visante/Pentacam/Orb Scan
Consent
Patients undergoing cataract surgery expect a good visual outcome. Glaucoma patients with vision compromised by optic nerve damage that will not be improved by cataract removal need to be realistic in their expectations: their surgery is NOT necessarily the same as that performed for their friends and relatives. The consent process needs to address this carefully and unambiguously so that the doctor and the patient have aligned hopes and expectations. with a Honan's balloon or a similar device can raise IOP to over 50 mmHg. 18 Topical anesthesia may be the preferred technique to try to avoid excess pressure on the globe (see The aims of surgery need to be clearly stated. In angleclosure patients where cataract removal aims to reopen the angle, the corrected vision may still be good, with minimal lens opacities. Vision is less likely to be improved but the aim is to improve IOP control, and to protect the angle structures from further damage (see Chapter 18) . Often these patients are hyperopic, with the surgery able to correct the refractive error. Cataract removal and IOL insertion in the other eye might be needed to correct anisometropia.
Preoperative Preparation for Cataract Surgery in the Glaucoma Patient
Most glaucoma patients instill one or more medications prior to cataract surgery. Commonest are the prostaglandin analogues (latanoprost, travoprost, or bimatoprost). This medication class, prior to and in the early postoperative phase, has been associated with cystoid macular edema. [20] [21] [22] The literature offers conflicting advice whether to withdraw a drug of this type. In advanced glaucomatous optic nerve atrophy where IOP fluctuation could result in visually significant compromise, glaucoma medications should be continued. In earlier stages of glaucoma when the IOP control is less critical, ceasing the glaucoma medications postoperatively provides an opportunity to assess the degree of IOP lowering from the cataract surgery alone, with the potential to reduce the number of medications and to avoid the increased risk of cystoid macula edema (see Chapter 4). A reverse therapeutic trial postoperatively may permit controlled cessation of one medication at a time. Chronic use of pilocarpine results in a small pupil that poorly dilates; previous cessation may make no difference. Pupil stretching or expanders are often required and should be anticipated (see Chapter 3) .
Especially in advanced glaucoma, IOP fluctuations might critically destroy surviving nerve fibers. Anticipate and manage them: a history of high IOP is a strong risk factor. 23 For example, it has been shown that IOP spikes greater than 30 mmHg in the first 24 h might be prevented by timolol maleate 0.5% at the end of the cataract procedure. 24 
Preoperative Peripheral Iridotomy
Angle-closure patients are at risk of pupil block if dilated. Peripheral iridotomy might be indicated to allow safe fundal examination preoperatively and if there is a delay in performing the surgery.
Anticoagulants
Patients on anticoagulants (including aspirin, non-steroidal anti-inflammatory drugs, warfarin, and clopidogrel) are at increased risk of hemorrhage. In some patients these medications can be ceased safely 10 days pre-surgery (4 days for warfarin) and restarted afterward. When it is critical for the patient to remain on the anticoagulant, consult with other doctors caring for the patient, and consider switching to heparin (e.g., subcutaneous enoxaparin) until the day of surgery. If anticoagulants cannot be ceased, a topical approach is preferable to avoid the bleeding risks of injection. Patients who are unsuitable for topical surgery may need a general anesthetic. Systemic anticoagulation has also been associated with the risk of suprachoroidal hemorrhage. 25 
Steroids
Topical and even oral steroids used preoperatively might help patients at risk of heightened inflammation. In uveitic glaucoma patients, quiet the eye as much and for as long as possible prior to surgery. With adequate inflammation suppression, phacotrabeculectomy with mitomycin C can be an effective and safe therapeutic option for secondary cataract and glaucoma in uveitic eyes. Lower surgical success rates might follow later resurgence of inflammation. 26 A combined cataract surgery with glaucoma drainage device is an alternative to phacotrabeculectomy. See Chapter 11.
Approach to Surgery
Glaucoma patients can present with visual loss from cataract and cataract patients can present with glaucoma. 27 The aims of surgery in each situation need to be defined clearly, with the doctor and patient reaching a common understanding. For most patients the perceived goal is often improved vision. This may not be achievable. It is for the doctor to communicate realistic aims, which include the following:
1. Improvement of vision if cataract is a significant cause of loss-the greater the loss from glaucoma, the less certain is such improvement. 2. Maintenance of vision if further loss from glaucoma is threatened. 3. Control of IOP if the cataract is involved in the mechanisms raising IOP or if a filtration operation is being performed to improve IOP control, or to allow cessation of medications with the concurrent existence of cataract to be managed.
Cataract Only
If visual field loss has been stabilized by adequate IOP control, perform cataract surgery when reduction in visual function interferes with daily living. Consider cataract surgery alone if glaucoma damage is relatively mild, when there are no other relevant ocular pathologies and visual improvement is likely. Provided IOP control is maintained postoperatively, no further procedure should be necessary. In other patients with mild-to-moderate elevation of IOP, cataract extraction alone may lower IOP adequately. Mathalone et al. evaluated long-term IOP control after sutureless clear corneal phacoemulsification in eyes with medically controlled glaucoma. At 12 months, mean IOP decrease was 1.5 mmHg ± 4.4 (SD), and 1.9 ± 4.9 mmHg at 24 months. The mean decrease in the number of medications was 0.53 ± 0.86 (P = 0.4) at 12 months and 0.38 ± 0.9 (P = 0.4) at 24 months. 28 Phacoemulsification in non-glaucomatous pseudoexfoliation syndrome patients significantly reduced IOP by about 3.5 mmHg at 1 year. 29 Pseudoexfoliative glaucoma patients demonstrated more IOP reduction than did normals and primary open angle glaucoma patients undergoing phacoemulsification. 30 In patients with primary angleclosure, both IOP and the need for glaucoma drugs could be reduced by phacoemulsification alone. 31 IOP fell from a mean preoperative level of 19.7 ± 6.1 mmHg (range 11-40 mmHg) to 15.5 ± 3.9 mmHg (range 9-26 mmHg) at final follow-up (P = 0.022) (paired t-test), while the number of glaucoma agents fell from a mean 1.91 ± 0.77 (range 1-3) to 0.52 ± 0.87 (range 0-3) at final follow-up (P < 0.001; paired t-test). Early phacoemulsification appeared to be more effective to prevent an IOP rise than laser peripheral iridoplasty in patients who had had an aborted episode of acute primary angle closure. 32 Phacoemulsification reduced the mean number of medications and consistently increased Shaffer gonioscopy grading. The effect of peripheral laser iridotomy compared with cataract surgery on the angle showed residual angle closure after iridotomy in 27 (38.6%) of 70 eyes; this was confirmed functionally by the dark room prone test and morphologically by ultrasound biomicroscopy (UBM). Eyes with IOP of ≥20 mmHg or with a glaucomatous visual field defect before iridotomy had a significantly higher prevalence of residual angle closure after iridotomy than did eyes without these findings (P<0.05). In all the eyes with residual angle closure after iridotomy, the response to the prone test became negative after cataract surgery, with significant lowering of IOP (P < 0.01). 33 Residual angle closure after iridotomy was common, especially in eyes with primary angle closure and poorly controlled IOP or glaucomatous optic neuropathy. Cataract surgery effectively resolved residual angle closure after iridotomy and lowered IOP. Using UBM, Nonaka et al. measured anterior chamber depth (ACD), angle opening distance at points 500 µm from the scleral spur (AOD500), and trabecular-ciliary process distance (TCPD). 34 Correlated with one another, all parameters increased significantly after cataract surgery (P < 0.001). Cataract surgery not only eliminated pupillary block but also attenuated any anterior positioning of the ciliary processes.
In 12 consecutive patients with end-stage glaucoma who underwent cataract surgery, 6 months postoperatively, Altmeyer et al. reported 35 improved mean visual acuity (from 0.3 to 0.5; P = 0.007) and decreased IOP (by 4.4 mmHg; P = 0.007); anti-glaucomatous drugs decreased in number from 1.5 preoperatively to 0.8, and mean deviation (MD) improved from -27.5 to -26.4 dB (P = 0.036). Thus patients with progressive cataract and end-stage glaucoma can benefit from cataract surgery.
Cataract and Glaucoma Surgery
Glaucoma patients with progressive visual loss and higher than desirable IOP, despite medical and laser strategies, require drainage surgery. In the presence of a visually significant cataract, determine whether cataract or glaucoma surgery or both are needed.
If the cataract is extracted first, IOP might fall. This is particularly likely if an angle-closure mechanism is eliminated before trabecular function has been damaged. 36 In open angle glaucoma patients, the reasons for reduced IOP after cataract surgery are less obvious.
Routine cataract surgery provokes subclinical inflammation. Increased flare after routine cataract surgery has been measured for up to 30 days postoperatively. 37 As this implies exaggerated wound healing, to optimize trabeculectomy function, it could be better to delay drainage at least until after this period. If IOP control is poor following cataract surgery, despite maximal tolerable medication, then drainage will be needed under suboptimal conditions, increasing likely benefit from anti-metabolite augmentation and/or pre-as well as postoperative topical and even oral steroids. Luo et al. measured mean aqueous flare values of 15.12 ± 2.87, 40.24 ± 3.75, 24.33 ± 3.38, 21.18 ± 1.77, and 16.51 ± 1.70 (photon counts/ms) preoperatively and on days 1, 7, 30, and 90, respectively, after trabeculectomy (P < 0.05) compared with 6.94 ± 2.34, 26.27 ± 10.21, 13.96 ± 6.44, 9.07 ± 2.67, and 7.16 ± 1.89, respectively, after phacoemulsification (P < 0.05). Trabeculectomy disrupted the blood-aqueous barrier permanently whilst phacoemulsification affected it transiently. 37 
Drainage Surgery Followed by Cataract Surgery
In patients with uncontrolled IOP it might be urgent to perform drainage prior to cataract surgery. When IOP is high and/or there is advanced glaucoma damage threatening fixation, there is potential for visual "snuff-out," especially with IOP spikes. Trabeculectomy was associated with progressive cataract-predominantly the posterior subcapsular variety. 38 Previously functioning drainage procedures can fail after cataract surgery, most likely by bleb exposure to induced inflammatory mediators. Approximately 50% of patients undergoing clear cornea phacoemulsification after trabeculectomy will require either further medication or further surgery to maintain target IOP. 39, 40 Identified risk factors for bleb failure include cataract extraction, age greater than 60 years, interval of 5 months or less between trabeculectomy and cataract extraction, use of pre-cataract extraction glaucoma medications, and postoperative IOP >19 mmHg within 2 weeks. 41 Cataract surgery after previously successful bleb needling revision significantly compromised bleb function. 42 To reduce the potential for fibrosis, subconjunctival 5-fluorouracil (5-FU) with or without needling can be useful. Sharma et al. retrospectively evaluated the protective role of subconjunctival 5-FU on a preexisting bleb in patients with primary open angle glaucoma undergoing phacoemulsification more than 12 months post-trabeculectomy. Data were collected for two groups of patients: Group 1 (22 patients) received 5-FU at the end of successful phacoemulsification, whereas group 2 (25 patients) did not. Reduced IOP control was seen in 13.6% of the patients in group 1 and in 36.4% in group 2 (P = 0.03). 5-FU seemed to protect bleb function. 43 Consider it at the end of phacoemulsification in such cases. See also Chapter 16. 44 This suggests less effective overall IOP reduction compared with trabeculectomy with mitomycin-C alone. Murthy et al. compared the 2-year outcomes of trabeculectomy with mitomycin-C (trabMMC) versus phacotrabeculectomy with mitomycin-C (phacotrabMMC). 45 Mean IOP drop from baseline was significantly greater with trab-MMC throughout the study (-10.87 ± 8.33 mmHg in trab-MMC versus -6.15 ± 7.01 mmHg in phacotrabMMC at 2 years, P = 0.003); however, baseline IOP was also higher in the trabMMC group (26.1 mmHg versus 20.3 mmHg, P < 0.0001). TrabMMC and phacotrabMMC may be equally safe and effective in bringing IOP to within an acceptable target range over 2 years in advanced glaucoma patients at increased risk for filtering surgery failure, although trab-MMC appears to be associated with greater IOP reduction.
Same-site or two-site combined surgery has been assessed with no clear superiority of either. 2, [45] [46] [47] The role of combined surgery is advantageous in elderly patients who are unsuitable for multiple procedures. Cotran et al. studied one-site versus two-site phacotrabeculectomy over a 3-year period. 48 The mean preoperative IOP was 20.1 ± 3.8 mmHg in the one-site group and 19.5 ± 5.3 mmHg in the twosite group (P = 0.56) using 2.3 ± 0.9 and 2.5 ± 0.9 antiglaucoma medications, respectively (P = 0.27). After 3 years, mean IOP was 12.6 ± 4.8 mmHg in the one-site group and 11.7 ± 4.0 mmHg in the two-site group (P = 0.40), instilling 0.3 ± 0.7 and 0.4 ± 0.9 medications, respectively (P = 0.59). At the end of the study, 73% of one-site eyes and 78.4% of two-site eyes had IOPs less than 18 mmHg on no anti-glaucoma medications (P = 0.59). Operating time was less in the one-site group (P < 0.0001). One-site fornix-based and two-site limbus-based phacotrabeculectomy were similarly effective in lowering IOP and in reducing the need for anti-glaucoma medications over a 3-year follow-up period. See Chapter 6.
Phacoemulsification can also be combined with a glaucoma drainage device, such as an Ahmed valve. Nassiri et al. reviewed 41 eyes in 31 patients who underwent combined phacoemulsification and Ahmed valve implantation. The mean IOP lowered from 28.2 ± 3.1 to 16.8 ± 2.1, while the number of anti-glaucoma medications fell from 2.6 ± 0.66 to 1.2 ± 1.4. An IOP of <21 mmHg on no medications or on one or more medications was achieved in 56.1 and 31.7%, respectively. Five eyes (12.2%) were considered failures (IOP < 6 mmHg or > 21 mmHg). 49 Other devices, such as the Eyepass glaucoma implant are under trial, but may not achieve consistent low target IOPs. 50 Traverso et al. and Rivier et al. have studied a stainless steel glaucoma drainage implant (Ex-PRESS). With a subconjunctival position, conjunctival erosion and extrusion were significant problems. 51, 52 Positioned under a scleral trapdoor, these problems have been addressed. 53 Combined phacoemulsification and ab interno trabeculectomy and endoscopiccontrolled erbium:YAG-laser goniotomy require more extensive study. 54, 55 Deep sclerectomy with phacoemulsification may be viable if augmented with intraoperative mitomycin C. There is reduced hypotensive efficacy compared with trabeculectomy but with less chance of cystic blebs, delayed bleb leaks, and infection. 56 Viscocanalostomy has also been combined with phacoemulsification. [57] [58] [59] [60] [61] Non-penetrating glaucoma surgery may not achieve low enough IOPs, especially for more advanced glaucoma patients. 62, 63 Larger long-term IOP fluctuations after this type of triple procedure were associated with progressive visual field deterioration even though patients with glaucoma maintained their IOPs. 64 Combined phacoemulsification and cyclophotocoagulation, either transscleral or endoscopic, is an option, particularly in patients unsuitable for drainage surgery. Problems are the narrow margins for success, with significant risks of uncontrolled IOP needing additional photocoagulation on the one hand, and of induced phthisis on the other. 65, 66 See Chapter 13.
Phacotrabeculectomy can be supplemented with early and repeated needle revisions with 5-FU to improve outcomes. 67 In "normal pressure glaucoma," phacoviscocanalostomy achieved 20% and 30% IOP reductions with (or without) medications in 78.5% (67.4%) and 35.5% (37.4%) of patients at 24 months, and 58.0% (44.2%) and 28.0% (26.6%) of patients at 48 months; these were better than in the cataract-extraction-only group, with only 16.0% (9.5%) and 5.7% (2.9%) at 24 months (P < 0.001 for each comparison, Kaplan-Meier life-table analysis with log-rank test). 61 Microincision bimanual phacotrabeculectomy may be an option as incision sizes reduce in future. 68 In aqueous misdirection glaucoma, a sequential three-step surgical approach has been suggested 69 : initial vitrectomy, phacoemulsification, and definitive vitrectomy.
Step 1: preliminary limited core vitrectomy to "debulk" the vitreous and soften the eye.
Step 2: phacoemulsification performed in a standard manner.
Step 3: residual vitrectomy, zonulohyaloidectomy, and peripheral iridectomy (if not already present) to create free communication between the posterior and anterior segments. 69 A novel combined approach is circumferential viscodilation and tensioning of the inner wall of Schlemm's canal (canaloplasty) to treat open angle glaucoma (OAG), combined with clear corneal phacoemulsification and posterior chamber IOL implantation. 70 The mean preoperative baseline IOP was 24.4 ± 6.1 mmHg (SD) with a mean of 1.5 ± 1.0 medications per eye. In all eyes, the mean postoperative IOP was 13.6 ± 3.8 mmHg at 1 month, 14.2 ± 3.6 mmHg at 3 months, 13.0 ± 2.9 mmHg at 6 months, and 13.7 ± 4.4 mmHg at 12 months. Medication use dropped to a mean of 0.2 ± 0.4 per patient at 12 months. Surgical complications were reported in five eyes (9.3%): hyphema (n = 3, 5.6%), Descemet's tear (n = 1, 1.9%), and iris prolapse (n = 1, 1.9%). Transient IOP elevation of >30 mmHg was observed in four eyes (7.3%) 1 day postoperatively. Canaloplasty is a complex procedure requiring expensive equipment; its longterm value remains to be demonstrated.
Summary
A careful history, thoughtful and thorough clinical assessment with the aid of emerging technologies, planned surgical steps, and a fully informed consent process will increase the chances of a satisfactory outcome for the majority of patients. The approach to surgery and the postoperative care is just as important as the surgery itself.
